Statement of deviation(s) or variation(s) under Reg. 32

October 28, 2026 The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/ Madam, Trading Symbol: ZOTA Sub: Statement of Deviation and/or Variation in utilization of Qualified Institutional Placement proceeds for the quarter ended September 30, 2026 Ref: Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject read with the SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, issued by SEBI for Statement of Deviation or Variation for proceeds of public issue, right issue, preferential issue, Qualified institution’s Placement (QIP) etc.; we, M/s Zota Health Care Limited, enclose herewith the Statement of Deviation and/ or Variation (No Deviation and/ or Variation) on the captioned subject. The above statement on Deviation and/ or Variation has been reviewed by the Audit Committee of the Board in its meeting held on October 28, 2026. This is for your information and record. Thanking you, Yours faithfully, For Zota Health Care Limited Ashvin Variya (Group Company Secretary & Compliance Officer) Place: Surat Encl.: a/a Registered Office: Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com CIN: L24231GJ2000PLC038352 Statement of Deviation / Variation in utilisation of funds raised (₹ in lakhs) Name of listed entity ZOTA HEALTH CARE LIMITED Mode of Fund Raising Qualified Institutions Placement Date of Raising Funds December 17, 2025 Amount Raised Rs. 34,999.99 lakhs comprising of Rs. 1,535/- per equity shares received on allotment of equity shares. This has been raised on December 17, 2025. Report filed for Quarter ended September 30, 2026 Monitoring Agency Applicable Monitoring Agency Name, if applicable CRISIL Ratings Limited Is there a Deviation / Variation in use of funds raised No If yes, whether the same is pursuant to change in terms of Not Applicable a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval Not Applicable Explanation for the Deviation / Variation Not Applicable Comments of the Audit Committee after review The Committee has noted that there is no deviation/ variation till the quarter ended September 30, 2026. Comments of the auditors, if any No comments Objects for which funds have been raised and where there has been a deviation, in the following table Original Object Modified Original Modified Funds Amount of Remarks Object, if any Allocation allocation, Utilised Deviation/Variation if (Refer if any for the quarter Any Note 1) according to applicable object Investment in DHML for Not Applicable 12,962.50 Not 1,814.91 Not Applicable Not setting-up of new COCO Applicable Applicable stores Funding the working Not Applicable 13,537.49 Not 8,286.60 Not Applicable capital requirements of Applicable the Company General Corporate Not Applicable 7,533.25 Not 1,433.60 Not Applicable Purpose Applicable Note 1: The Company has raised Rs. 34,999.99 lakhs and the Net proceeds after deducting the issue expenses available for the utilisation is Rs. 34,033.24 lakhs. For Zota Health Care Limited Ashvin Variya (Group Company Secretary & Compliance Officer) Date: 28.10.2026